$NGTF
NightFood Holdings, Inc. Stock $ngtf

$ngtf Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000121390024028649 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4
Revenue	$1.352K	$601.00
YoY Change	-87.25%	-95.5%
Cost Of Revenue	$2.030K	$1.000K
YoY Change	-96.53%	-97.62%
Gross Profit	-$680.00	-$400.00
YoY Change	-98.58%	-98.6%
Gross Profit Margin	-50.3%	-66.56%
Selling, General & Admin	$162.0K	$53.44K
YoY Change	4.48%	-48.76%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$291.5K	$175.3K
YoY Change	87.26%	-74.63%
Operating Profit	-$290.1K	-$174.7K
YoY Change	100.02%	-74.22%
Interest Expense	-$86.14K	-$115.3K
YoY Change	-105.2%	-96.62%
% of Operating Profit
Other Income/Expense, Net	-$379.6K	-$201.5K
YoY Change	-133.56%
Pretax Income	-$669.7K	-$491.5K
YoY Change	-167.93%	-89.22%
Income Tax
% Of Pretax Income
Net Earnings	-$669.7K	-$491.5K
YoY Change	-167.93%	-89.22%
Net Earnings / Revenue	-49535.43%	-81772.71%
Basic Earnings Per Share	-$0.01	$0.00
Diluted Earnings Per Share	-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	127.9M shares	126.9M shares
Diluted Shares Outstanding	127.7M shares	127.2M shares

Balance Sheet

Concept	2024 Q1	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$186.1K	$5.800K
YoY Change	597.94%	-88.17%
Cash & Equivalents	$186.1K	$5.804K
Short-Term Investments
Other Short-Term Assets	$187.2K	$133.4K
YoY Change	101.59%	29.49%
Inventory	$35.84K	$133.4K
Prepaid Expenses	$5.978K	$11.51K
Receivables	$25.66K	$30.28K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$434.8K	$302.9K
YoY Change	-23.54%	-55.47%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$1.333M
YoY Change
Intangibles	$1.333M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$302.0K
YoY Change
Total Long-Term Assets	$1.635M	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$434.8K	$302.9K
Total Long-Term Assets	$1.635M	$0.00
Total Assets	$2.070M	$302.9K
YoY Change	264.01%	-55.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$648.7K	$604.8K
YoY Change	21.58%	17.43%
Accrued Expenses	$234.4K	$143.0K
YoY Change	164.33%	429.44%
Deferred Revenue
YoY Change
Short-Term Debt	$2.990M	$2.197M
YoY Change	249.69%	-33.77%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.124M	$3.106M
YoY Change	179.15%	-19.53%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.124M	$3.106M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$4.124M	$3.106M
YoY Change	179.15%	-19.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.65M	-$36.93M
YoY Change	10.75%	-1.64%
Common Stock	$127.9K	$127.2K
YoY Change	12.15%	27.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.054M	-$2.803M
YoY Change
Total Liabilities & Shareholders Equity	$2.070M	$302.9K
YoY Change	264.01%	-55.47%

Cashflow Statement

Concept	2024 Q1	2023 Q4
OPERATING ACTIVITIES
Net Income	-$669.7K	-$491.5K
YoY Change	-167.93%	-89.22%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$109.4K	-$250.0K
YoY Change	-57.51%	-22.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$326.0K
YoY Change
Cash From Investing Activities	-$326.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	615.7K	250.4K
YoY Change	161.86%	64.57%
NET CHANGE
Cash From Operating Activities	-109.4K	-250.0K
Cash From Investing Activities	-326.0K
Cash From Financing Activities	615.7K	250.4K
Net Change In Cash	180.3K	380.0
YoY Change	-906.94%	-100.22%
FREE CASH FLOW
Cash From Operating Activities	-$109.4K	-$250.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.015
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127162606	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	95075293	shares
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55406
	dei	Entity Registrant Name EntityRegistrantName	NIGHTFOOD HOLDINGS, INC.
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3885019
	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 White Plains Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Tarrytown
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10591
	dei	City Area Code CityAreaCode	888
	dei	Local Phone Number LocalPhoneNumber	888-6444
	dei	Security12b Title Security12bTitle	N/A
	dei	No Trading Symbol Flag NoTradingSymbolFlag	true
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127907407	shares
	us-gaap	Professional Fees ProfessionalFees	841397	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	175271	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	690908	usd
	us-gaap	Operating Expenses OperatingExpenses	608931	usd
	us-gaap	Operating Expenses OperatingExpenses	1329485	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5804	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44187	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	30281	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	33396	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	133371	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	276202	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	133410	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	302866	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	446511	usd
CY2023Q4	us-gaap	Assets Assets	302866	usd
CY2023Q2	us-gaap	Assets Assets	446511	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	747702	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	604516	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2196981	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1491719	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3105584	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2198111	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127221301	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127221301	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123587968	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123587968	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	127221	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	123588	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34003451	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	33112935	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36933393	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34988126	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2802718	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1751600	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	302866	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	446511	usd
CY2023Q4	us-gaap	Revenues Revenues	601	usd
CY2022Q4	us-gaap	Revenues Revenues	13369	usd
	us-gaap	Revenues Revenues	9071	usd
	us-gaap	Revenues Revenues	93339	usd
CY2023Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	996	usd
CY2022Q4	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	41996	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	58576	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	167117	usd
CY2023Q4	ngtf	Advertising And Promotional AdvertisingAndPromotional	6722	usd
CY2022Q4	ngtf	Advertising And Promotional AdvertisingAndPromotional	53169	usd
	ngtf	Advertising And Promotional AdvertisingAndPromotional	-409	usd
	ngtf	Advertising And Promotional AdvertisingAndPromotional	90335	usd
CY2023Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	53437	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	104292	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	213448	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	230636	usd
CY2023Q4	us-gaap	Professional Fees ProfessionalFees	114116	usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees	491448	usd
	us-gaap	Professional Fees ProfessionalFees	337316	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-174670	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-677539	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-599860	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1236146	usd
CY2023Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	63040	usd
CY2022Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	34382	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	106736	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	57328	usd
CY2023Q4	us-gaap	Financing Interest Expense FinancingInterestExpense	52260	usd
CY2022Q4	us-gaap	Financing Interest Expense FinancingInterestExpense	3377927	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	804160	usd
	us-gaap	Financing Interest Expense FinancingInterestExpense	3510910	usd
CY2023Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	201481	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	484907	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	413740	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1029452	usd
CY2022Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	14493	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	72464	usd
CY2023Q4	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	316784	usd
CY2022Q4	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3882723	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1324636	usd
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	4525226	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-491454	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-4560262	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1924496	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5761372	usd
CY2022Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	3340203	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	20771	usd
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	3685665	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-491454	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7900465	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1945267	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9447037	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.004
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.015
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.1
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	127162606	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	97436644	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125973113	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	95075293	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1751600	usd
CY2023Q3	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	50000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	84230	usd
CY2023Q3	ngtf	Stock Issued During Period Value Warrants Issued As Financing Cost Associated With Convertible Notes StockIssuedDuringPeriodValueWarrantsIssuedAsFinancingCostAssociatedWithConvertibleNotes	9878	usd
CY2023Q3	ngtf	Warrants Issued As Financing Cost WarrantsIssuedAsFinancingCost	699350	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1433042	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2341184	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	7800	usd
CY2023Q4	ngtf	Warrants Issued As Financing Cost WarrantsIssuedAsFinancingCost	22120	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-491454	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-2802718	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	265576	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	20010	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	290070	usd
CY2022Q3	ngtf	Warrants Issued And Warrants Dilutive Adjustment As Financing Cost WarrantsIssuedAndWarrantsDilutiveAdjustmentAsFinancingCost	65783	usd
CY2022Q3	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustment	108126	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-1201110	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-451545	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	224615	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	16000	usd
CY2022Q4	ngtf	Common Stock Issued As Financing Cost CommonStockIssuedAsFinancingCost	60000	usd
CY2022Q4	ngtf	Stock Isuued Vested Warrants For Services StockIsuuedVestedWarrantsForServices	5250	usd
CY2022Q4	ngtf	Adjustments To Additional Paid In Capital Warrant Dilutive Other Adjustment AdjustmentsToAdditionalPaidInCapitalWarrantDilutiveOtherAdjustment	305829	usd
CY2022Q4	ngtf	Warrants Issued And Warrants Dilutive Adjustment As Financing Cost WarrantsIssuedAndWarrantsDilutiveAdjustmentAsFinancingCost	1220790	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-4560262	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3179323	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1924496	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5761372	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	84230	usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	419205	usd
	ngtf	Warrants And Returnable Warrants Issued For Financing Cost WarrantsAndReturnableWarrantsIssuedForFinancingCost	721470	usd
	ngtf	Warrants And Returnable Warrants Issued For Financing Cost WarrantsAndReturnableWarrantsIssuedForFinancingCost	1286573	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7800	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	36010	usd
	ngtf	Stock Issued For Financing Costs StockIssuedForFinancingCosts	50000	usd
	ngtf	Stock Issued For Financing Costs StockIssuedForFinancingCosts	60000	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	413740	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1029452	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	72464	usd
	ngtf	Financing Cost Due To Conversion Price Adjustments FinancingCostDueToConversionPriceAdjustments	-1843475	usd
	ngtf	Financing Cost Due To Default FinancingCostDueToDefault	181159	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	145555	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-46130	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3115	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-19253	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2724	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	122086	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	86814	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-34771	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	143187	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	283859	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	59024	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	24000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-339783	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-738165	usd
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	224615	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	301400	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	644000	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-362319	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	301400	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	506296	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-38383	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-231869	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44187	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	280877	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5804	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49008	usd
	us-gaap	Interest Paid Net InterestPaidNet	39452	usd
	ngtf	Warrants And Returnable Warrants Issued For Financing Costs WarrantsAndReturnableWarrantsIssuedForFinancingCosts	721470	usd
	ngtf	Warrants And Returnable Warrants Issued For Financing Costs WarrantsAndReturnableWarrantsIssuedForFinancingCosts	1286573	usd
	us-gaap	Stock Issued1 StockIssued1	50000	usd
	us-gaap	Stock Issued1 StockIssued1	60000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	850	usd
	ngtf	Deemed Dividend Associated With Preferred B Stock And Dilutive Warrant Adjustments DeemedDividendAssociatedWithPreferredBStockAndDilutiveWarrantAdjustments	20771	usd
	ngtf	Deemed Dividend Associated With Preferred B Stock And Dilutive Warrant Adjustments DeemedDividendAssociatedWithPreferredBStockAndDilutiveWarrantAdjustments	3685665	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	63066	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>1. Description of Business and Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Nightfood Holdings, Inc. (“we”, “us”, “the Company” or “Nightfood”) is a Nevada corporation incorporated on October 16, 2013, to acquire all of the issued and outstanding shares of Nightfood, Inc., a New York corporation from its sole shareholder, Sean Folkson. For the reporting period, all of our operations were being conducted through subsidiary Nightfood, Inc. We are also the sole shareholder of MJ Munchies, Inc., currently revoked in the State of Nevada, which owns certain intellectual property, but does not have any operations as of the period covered by these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">Our corporate address is 520 White Plains Road – Suite 500, Tarrytown, New York 10591 and our telephone number is 888-888-6444. We maintain a web site at www.nightfood.com, along with many additional web properties. Any information that may appear on our web site should not be deemed to be a part of this report.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white">The Company’s fiscal year end is June 30.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Going Concern</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s financial statements are prepared using generally accepted accounting principles, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. No certainty of continuation can be stated.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. For the six months ended December 31, 2023, the Company had an operating and net loss of $1,945,267, cash flow used in operations of $339,783 and an accumulated deficit of $36,933,393.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has limited available cash resources and we do not believe our cash on hand will be sufficient to fund our operations and growth throughout fiscal year 2024 or adequate to satisfy our immediate or ongoing working capital needs. We are currently in default with respect to the terms of several of our convertible notes payable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"> </td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is continuing to seek to raise capital through the sales of its common stock, preferred stock and/or convertible notes, as well as potentially the exercise of outstanding warrants, to finance the Company’s operations, of which it can give no assurance of success. Management has devoted a significant amount of time to the raising of capital from additional debt and equity financing. However, the Company’s ability to continue as a going concern is dependent upon raising additional funds through debt and equity financing and generating revenue. Additionally, management is investing in the acquisition of additional revenue generating assets through the issuance of debt and/or equity to further assist the Company’s growth initiatives. As of December 31, 2023 we have advanced proceeds totaling $92,500 to potential acquisition targets, which were acquired subsequent to the reporting period (ref: Note 15).</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because the Company has limited sales, no certainty of continuation can be stated. The Company’s ability to continue as a going concern is dependent upon raising additional funds through debt and equity financing and generating revenue. In addition, the Company will receive the proceeds from its outstanding warrants as, if and when such warrants are exercised for cash. There are no assurances the Company will receive the necessary funding or generate revenue necessary to fund operations.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Even if the Company is successful in raising additional funds, the Company cannot give any assurance that it will, in the future, be able to achieve a level of profitability from the sale of its products to sustain its operations. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on recoverability and reclassification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From both public statements observed, and conversations conducted between Nightfood management and current and former executives from certain global food and beverage conglomerates, it has been affirmed to management that there is increased strategic interest in the nighttime nutrition space as a potential high-growth opportunity, partially due to recent declines in consumer sleep quality and increases in at-home nighttime snacking.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has experienced no major issues with supply chain or logistics. Order processing function has been normal to date, and its manufacturers have assured the Company that their operations are “business as usual” as of the time of this filing.</span></td></tr> </table>
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1945267	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-339783	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36933393	usd
CY2023Q4	ngtf	Amounts Advanced For Operations Of Acquisition Targets Secured By Promissory Notes AmountsAdvancedForOperationsOfAcquisitionTargetsSecuredByPromissoryNotes	92500	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Use of Estimates</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates are used in the determination of depreciation and amortization, the valuation for non-cash issuances of common stock, and the website, income taxes and contingencies, valuing convertible preferred stock for a “beneficial conversion feature” (“BCF”) and warrants among others.</span></td> </tr></table>
	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023Q4	ngtf	Inventory Balances InventoryBalances	32359	usd
	ngtf	Inventory Balances InventoryBalances	145555	usd
CY2023Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6722	usd
CY2022Q4	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	53169	usd
	ngtf	Advertising Costs AdvertisingCosts	409	usd
	ngtf	Advertising Costs AdvertisingCosts	90335	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="background-color: white"><b>Concentration of Credit Risk</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash deposits at financial institutions. At various times during the year, the Company may exceed the federally insured limits. To mitigate this risk, the Company places its cash deposits only with high credit quality institutions. Management believes the risk of loss is minimal. At December 31, 2023 and June 30, 2023, the Company did not have any uninsured cash deposits.</span></td> </tr></table>
	ngtf	Description Of Beneficial Conversion Feature DescriptionOfBeneficialConversionFeature	(i) 5,000 shares of the Registrant’s common stock (one share for each $0.20 of liquidation preference) (the “Conversion Shares”) and (ii) 5,000 common stock purchase warrants, expiring April 16, 2026 (the “Warrants”). The Warrants carried an initial exercise price of $0.30 per share. Subsequent financing events and debt extinguishment resulted in adjustments to the exercise price of all warrants created from conversion of B Preferred from $0.30 per share to approximately $0.1247 per share through December 31, 2023.
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4400000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1100000	usd
CY2023Q4	ngtf	Number Of Customer NumberOfCustomer	1	customer
	ngtf	Number Of Customer NumberOfCustomer	1	customer
	ngtf	Customer Concentration Risk Percentage CustomerConcentrationRiskPercentage	0.10	pure
	ngtf	Number Of Customer NumberOfCustomer	4	customer
	ngtf	Customer Concentration Risk Percentage CustomerConcentrationRiskPercentage	0.83	pure
CY2022Q4	ngtf	Number Of Customer NumberOfCustomer	2	customer
CY2022Q4	ngtf	Customer Concentration Risk Percentage CustomerConcentrationRiskPercentage	0.97	pure
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	133410	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	92726	usd
CY2023Q4	ngtf	Number Of Vendor NumberOfVendor	1	vendor
	ngtf	Number Of Vendor NumberOfVendor	1	vendor
	ngtf	Vendor Concentration Risk Percentage VendorConcentrationRiskPercentage	0.10	pure
CY2022Q4	ngtf	Number Of Vendor NumberOfVendor	2	vendor
	ngtf	Number Of Vendor NumberOfVendor	2	vendor
	ngtf	Vendor Concentration Risk Percentage VendorConcentrationRiskPercentage	0.10	pure
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white"><b>Reclassification</b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may make certain reclassifications to prior period amounts to conform with the current year’s presentation. Such reclassifications would not have a material effect on its consolidated statement of financial position, results of operations or cash flows.</span></td> </tr></table>
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	91883	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	163644	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	33166	usd
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	63734	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	8322	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	48824	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	133371	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	276202	usd
CY2023Q4	us-gaap	Inventory Adjustments InventoryAdjustments	145555	usd
CY2023Q4	ngtf	Amounts Advanced For Operations Of Acquisition Targets Secured By Promissory Notes AmountsAdvancedForOperationsOfAcquisitionTargetsSecuredByPromissoryNotes	92500	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	11514	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	29396	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	92726	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	142946	usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent	40779	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	604756	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	563737	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	747702	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	604516	usd
CY2022Q4	ngtf	Convertible Price Per Share ConvertiblePricePerShare	0.2
CY2023Q4	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	1000000	usd
	us-gaap	Noninterest Expense Transfer Agent And Custodian Fees NoninterestExpenseTransferAgentAndCustodianFees	100000	usd
	us-gaap	Legal Fees LegalFees	15192	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	5434783	shares
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1086957	shares
	ngtf	Forbearance Agreement Description ForbearanceAgreementDescription	The Company shall pay to each Purchaser in cash the sum of $482,250.00 for the full and complete satisfaction of the Notes, which includes all due and owing principal, interest and penalties notwithstanding anything to the contrary in the Notes, as follows: (i) $250,000.00 on or before February 7, 2023; (ii) $50,000.00 on or before February 28, 2023; (iii) $50,000.00 on or before March 31, 2023; (iv) $50,000.00 on or before April 30, 2023; and (v) $82,250.00 on or before May 31, 2023.
	ngtf	Schedule Of Exchange Of Returnable Warrants For Shares Of Common Stock ScheduleOfExchangeOfReturnableWarrantsForSharesOfCommonStock	<span style="background-color: white">Below is a reconciliation of the extinguishment of debt relative to the exchange of Returnable Warrants for shares of common stock by the holders:</span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">3,800,000 shares of common stock issued and exchanged for 10,869,566 returnable warrants</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">342,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Loss on conversion price change in December 31, 2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,051,801</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock settled debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,988,402</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Financing charges due to returnable warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">987,060</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Principal increased due to penalty</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">58,703</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Loss on extinguishment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">392,459</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table>
CY2023Q4	ngtf	Shares Of Common Stock Issued Returnable Warrants SharesOfCommonStockIssuedReturnableWarrants	3800000	shares
	ngtf	Shares Of Common Stock Exchanged For Returnable Warrants SharesOfCommonStockExchangedForReturnableWarrants	10869566	shares
CY2023Q4	ngtf	Common Stock Returnable Warrants CommonStockReturnableWarrants	342000	usd
	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	1051801	shares
	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	1988402	usd
CY2023Q4	ngtf	Financing Charges Due To Returnable Warrants Issued FinancingChargesDueToReturnableWarrantsIssued	987060	usd
	ngtf	Under Forbearance Agreement UnderForbearanceAgreement	58703	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	392459	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	62000	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	52700	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	420627	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	960197	usd
CY2022Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	20071	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	41617	usd
CY2022Q4	us-gaap	Interest Costs Incurred InterestCostsIncurred	440698	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	1001814	usd
	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	604800	usd
CY2023Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	49995	usd
CY2023Q2	us-gaap	Stock Issued1 StockIssued1	16088	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	33907	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	7000000	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q1	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
	ngtf	Warrants To Purchase Shares WarrantsToPurchaseShares	57000	shares
CY2023Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.1
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	169941	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	136800	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	24141	usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1790000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1820000	shares
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	200000	usd
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	170000	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	30000	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	0.033	shares
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	62000	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	52700	usd
CY2023Q4	us-gaap	Short Duration Contracts Discounted Liabilities Amount ShortDurationContractsDiscountedLiabilitiesAmount	9300	usd
CY2023Q4	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	0.033
CY2023Q4	us-gaap	Prepayment Fees On Advances Net PrepaymentFeesOnAdvancesNet	750	usd
CY2023Q4	ngtf	Outstanding Principal Amount Percentage OutstandingPrincipalAmountPercentage	0.50	pure
CY2023Q4	ngtf	Repayment Repayment	1.50	pure
CY2023Q4	ngtf	Cash Fee CashFee	5270	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	159697	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2023Q4	ngtf	Discount Issue DiscountIssue	9300	usd
CY2023Q4	ngtf	Cash Fee CashFee	5270	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	159697	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	170588	usd
CY2023Q4	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	145000	usd
CY2023Q4	ngtf	Discount Issue DiscountIssue	25588	usd
CY2023Q4	ngtf	Cash Fee CashFee	14500	usd
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	439394	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2023Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	55250	usd
CY2023Q2	ngtf	Purchase Issue Amount PurchaseIssueAmount	9750	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	600000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.1
CY2023Q2	ngtf	Common Stock As Commitment Shares CommonStockAsCommitmentShares	1477272	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	650000	shares
	ngtf	Cash Fee CashFee	5100	usd
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	650000	shares
	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.033
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	142946	usd
CY2023Q2	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	40779	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.03333
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	ngtf	Outstanding Share In Percentage OutstandingShareInPercentage	0.50	pure
	ngtf	Offering Description OfferingDescription	the Company launched a Tier 2 offering pursuant to Regulation A (also known as “Regulation A+”) with the intent to raise capital through an equity crowdfunding campaign. The Company is offering (this “Offering”) up to 5,000,000 units, each unit consisting of 4 shares of common stock and 4 common stock purchase warrants (“Unit”), being offered at a price range to be determined after qualification pursuant to Rule 253(b).
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	300000	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	7800	usd
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	457350	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.5
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	224615	usd
CY2023Q2	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	0	shares
CY2022Q2	us-gaap	Investment Sold Not Yet Purchased Balance Shares InvestmentSoldNotYetPurchasedBalanceShares	335	shares
	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	0	usd
	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	335000	usd
CY2023Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	5000	shares
CY2023Q4	ngtf	Warrants warrants	5000	shares
	ngtf	Transaction Amount TransactionAmount	4431387	usd
	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	1136946	usd
CY2022	ngtf	Warrants Issued WarrantsIssued	4000000	shares
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.25
CY2022Q2	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	1.4339	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0125	pure
CY2023	us-gaap	Subsidiary Or Equity Method Investee Cumulative Number Of Shares Issued For All Transactions SubsidiaryOrEquityMethodInvesteeCumulativeNumberOfSharesIssuedForAllTransactions	12870000	shares
CY2023	ngtf	Aggregate Of Shares AggregateOfShares	6549128	shares
CY2023	ngtf	Stock Purchase Warrants StockPurchaseWarrants	4928260	shares
CY2023Q2	us-gaap	Long Duration Contracts Assumptions By Product And Guarantee Volatility Rate LongDurationContractsAssumptionsByProductAndGuaranteeVolatilityRate	1.2175	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0406	pure
CY2023	ngtf	Aggregate Common Stock Shares AggregateCommonStockShares	5750000	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.05
CY2023	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	276066	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	377560	usd
	ngtf	Warrants Issued WarrantsIssued	650000	shares
CY2023Q3	ngtf	Returnable Warrants Issued ReturnableWarrantsIssued	7000000	shares
CY2023Q3	ngtf	Additional Financing Costs In Cumulative Amount AdditionalFinancingCostsInCumulativeAmount	699350	usd
CY2023Q4	ngtf	Outstanding Share Purchase Warrants OutstandingSharePurchaseWarrants	25539751	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.1247
	ngtf	Warrant Description WarrantDescription	Certain warrants in the below table include dilution protection for the warrant holders, which could cause the exercise price to be adjusted either higher or lower as a result of various financing events and stock transactions. The result of the warrant exercise price downward adjustment on modification date is treated as a deemed dividend and fully amortized on the transaction date. In addition to the reduction in exercise price, with certain warrants there is a corresponding increase to the number of warrants to the holder on a prorated basis. Under certain conditions, such as the successful retirement of a convertible note through repayment, it is possible for the exercise price of these warrants to increase and for the number of warrants outstanding to decrease.
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	6570000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	4220000	usd
CY2023Q4	ngtf	Cash Performance Rate CashPerformanceRate	0.02	pure
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.10	pure
	ngtf	Average Closing Priced Trading Day AverageClosingPricedTradingDay	10	pure
CY2023Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.12	pure
CY2023Q4	ngtf	Consulting Fees ConsultingFees	53625	usd
CY2023Q2	ngtf	Consulting Fees ConsultingFees	27000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	ngtf	Exchange Agreement Description ExchangeAgreementDescription	(i) all 1,000 issued and outstanding shares of NGTF’s Series Super Voting A Preferred Stock held by the NGTF Series A Shareholder, and (ii) an aggregate of 13,333 newly issued shares of NGTF’s Series C Convertible Preferred Stock, each of which shall convert into 6,000 shares of common stock at $0.025 per share (the “Series C Preferred Stock”, and together with the Series A Super Voting Preferred Stock, the “NGTF Exchange Shares”).
CY2023Q4	us-gaap	Cost Of Services Catering CostOfServicesCatering	57000	usd
CY2023Q2	ngtf	Principal Amount PrincipalAmount	65000	usd
CY2023Q3	ngtf	Purchase Price PurchasePrice	60000	usd
CY2023Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash		usd
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.004
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125973113	shares
CY2023Q3	ngtf	Deemed Dividends Associated With Warrants Related Dilutive Adjustments DeemedDividendsAssociatedWithWarrantsRelatedDilutiveAdjustments		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q3	ngtf	Deemed Dividends Associated With Related Dilutive Warrant Adjustments DeemedDividendsAssociatedWithRelatedDilutiveWarrantAdjustments		usd
CY2022Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022Q4	ngtf	Deemed Dividends Associated With Related Dilutive Warrant Adjustments DeemedDividendsAssociatedWithRelatedDilutiveWarrantAdjustments		usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
	ngtf	Financing Cost Due To Conversion Price Adjustments FinancingCostDueToConversionPriceAdjustments		usd
	ngtf	Financing Cost Due To Default FinancingCostDueToDefault		usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1		usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction		usd
CY2023Q2	ngtf	Amounts Advanced For Operations Of Acquisition Targets Secured By Promissory Notes AmountsAdvancedForOperationsOfAcquisitionTargetsSecuredByPromissoryNotes		usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
CY2023Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001593001

Files In Submission

Name	View Source	Status
0001213900-24-028649-index-headers.html	Edgar Link	pending
0001213900-24-028649-index.html	Edgar Link	pending
0001213900-24-028649.txt	Edgar Link	pending
0001213900-24-028649-xbrl.zip	Edgar Link	pending
ea0202837-10q_nightfood.htm	Edgar Link	pending
ea020283701ex31-1_nightfood.htm	Edgar Link	pending
ea020283701ex32-1_nightfood.htm	Edgar Link	pending
ea020283701ex4-3_nightfood.htm	Edgar Link	pending
ea020283701ex4-6_nightfood.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ngtf-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ngtf-20231231_cal.xml	Edgar Link	unprocessable
ngtf-20231231_def.xml	Edgar Link	unprocessable
ngtf-20231231_lab.xml	Edgar Link	unprocessable
ngtf-20231231_pre.xml	Edgar Link	unprocessable
ea0202837-10q_nightfood_htm.xml	Edgar Link	completed
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NGTF
NightFood Holdings, Inc. Stock $ngtf

2024 Q1 Form 10-Q Financial Statement

#000121390024028649 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF NightFood Holdings, Inc. Stock $ngtf

2024 Q1 Form 10-Q Financial Statement

#000121390024028649 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NGTF
NightFood Holdings, Inc. Stock $ngtf